πŸ‡ΊπŸ‡Έ FDA
Patent

US 9610309

Liquid viral formulations

granted A61KA61K2039/525A61K35/76

Quick answer

US patent 9610309 (Liquid viral formulations) held by ONCOLYTICS BIOTECH INC. expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K2039/525, A61K35/76, A61K35/765, A61K39/15